These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 19890494)

  • 1. Epigenetic targeting in breast cancer: therapeutic impact and future direction.
    Lustberg MB; Ramaswamy B
    Drug News Perspect; 2009 Sep; 22(7):369-81. PubMed ID: 19890494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current and upcoming approaches to exploit the reversibility of epigenetic mutations in breast cancer.
    Falahi F; van Kruchten M; Martinet N; Hospers GA; Rots MG
    Breast Cancer Res; 2014 Jul; 16(4):412. PubMed ID: 25410383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic Therapy in Breast Cancer.
    Lustberg MB; Ramaswamy B
    Curr Breast Cancer Rep; 2011 Mar; 3(1):34-43. PubMed ID: 23097683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic mechanisms of breast cancer: an update of the current knowledge.
    Karsli-Ceppioglu S; Dagdemir A; Judes G; Ngollo M; Penault-Llorca F; Pajon A; Bignon YJ; Bernard-Gallon D
    Epigenomics; 2014; 6(6):651-64. PubMed ID: 25531258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetics of Breast Cancer: Clinical Status of Epi-drugs and Phytochemicals.
    Shukla S; Penta D; Mondal P; Meeran SM
    Adv Exp Med Biol; 2019; 1152():293-310. PubMed ID: 31456191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic and Therapeutic Implications of Histone Epigenetic Modulators in Breast Cancer.
    Walsh L; Gallagher WM; O'Connor DP; Ní Chonghaile T
    Expert Rev Mol Diagn; 2016; 16(5):541-51. PubMed ID: 26895288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Harnessing Epigenetics for Breast Cancer Therapy: The Role of DNA Methylation, Histone Modifications, and MicroRNA.
    Szczepanek J; Skorupa M; Jarkiewicz-Tretyn J; Cybulski C; Tretyn A
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the Epigenome as a Novel Therapeutic Approach for Breast Cancer.
    Oh S; Ko JY; Oh C; Yoo KH
    Adv Exp Med Biol; 2017; 1026():287-313. PubMed ID: 29282690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic Modulations in Breast Cancer: An Emerging Paradigm in Therapeutic Implications.
    Sarkar S; Venkatesh D; Kandasamy T; Ghosh SS
    Front Biosci (Landmark Ed); 2024 Aug; 29(8):287. PubMed ID: 39206915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic modulators as therapeutic targets in prostate cancer.
    Graça I; Pereira-Silva E; Henrique R; Packham G; Crabb SJ; Jerónimo C
    Clin Epigenetics; 2016; 8():98. PubMed ID: 27651838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct monitoring of breast and endometrial cancer cell epigenetic response to DNA methyltransferase and histone deacetylase inhibitors.
    Teixeira SR; Abreu CM; Parkes L; Davies J; Yao S; Sawhney MA; Margarit L; Gonzalez D; Pinto IM; Francis LW; Conlan RS
    Biosens Bioelectron; 2019 Sep; 141():111386. PubMed ID: 31220725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic Modulators as Therapeutic Agents in Cancer.
    Patnaik E; Madu C; Lu Y
    Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histone Deacetylase Inhibitors: An Attractive Therapeutic Strategy Against Breast Cancer.
    Damaskos C; Garmpis N; Valsami S; Kontos M; Spartalis E; Kalampokas T; Kalampokas E; Athanasiou A; Moris D; Daskalopoulou A; Davakis S; Tsourouflis G; Kontzoglou K; Perrea D; Nikiteas N; Dimitroulis D
    Anticancer Res; 2017 Jan; 37(1):35-46. PubMed ID: 28011471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic therapy of cancer with histone deacetylase inhibitors.
    Lakshmaiah KC; Jacob LA; Aparna S; Lokanatha D; Saldanha SC
    J Cancer Res Ther; 2014; 10(3):469-78. PubMed ID: 25313724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic therapy for breast cancer.
    Cai FF; Kohler C; Zhang B; Wang MH; Chen WJ; Zhong XY
    Int J Mol Sci; 2011; 12(7):4465-87. PubMed ID: 21845090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting epigenetics for the treatment of prostate cancer: recent progress and future directions.
    Lin J; Wang C; Kelly WK
    Semin Oncol; 2013 Jun; 40(3):393-401. PubMed ID: 23806502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
    Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
    J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast cancer epigenetics: current and evolving treatment.
    Purja S; Nguyen DT; Kim E
    Breast Cancer; 2024 Sep; 31(5):869-885. PubMed ID: 38861041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic Targets and their Inhibitors in Cancer Therapy.
    Zhao L; Duan YT; Lu P; Zhang ZJ; Zheng XK; Wang JL; Feng WS
    Curr Top Med Chem; 2018; 18(28):2395-2419. PubMed ID: 30582481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenomes as therapeutic targets.
    Hamm CA; Costa FF
    Pharmacol Ther; 2015 Jul; 151():72-86. PubMed ID: 25797698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.